Loading company…
Sinomune develops pharmaceutical and skincare products, with a focus on dermatological conditions.
Founded in 1999 and based in Wuxi, China, Sinomune develops medicines and functional skincare products for conditions including fungal infections, acne, and inflammatory diseases. It distributes products across Asia through established brands. In December 2025, the company raised approximately CNY 300 million in Pre-IPO funding led by Sinovation Ventures and Cathay Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in